Excess length of stay due to central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico

Infection Control and Hospital Epidemiology

Volumn 31, Issue 11, 2010, Pages 1106-1114

  Barnett, Adrian G ^a   Graves, Nicholas ^a   Rosenthal, Victor D ^b   Salomao, Reinaldo ^c   Rangel Frausto, Manuel Sigfrido ^d  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b International Nosocomial Infection Control Consortium   (Argentina)

^c HOSPITAL SANTA MARCELINA   (Brazil)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARGENTINA; ARTICLE; BLOODSTREAM INFECTION; BRAZIL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEXICO;

ARGENTINA; BRAZIL; CATHETER-RELATED INFECTIONS; COHORT STUDIES; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MEXICO; MODELS, STATISTICAL;

EID: 77957878813     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/656593     Document Type: Article

References (38)

1. Crnich CJ, Maki DG. The role of intravascular devices in sepsis. Curr Infect Dis Rep 2001;3(6):496-506.
2. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical- surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003;31(5):291-295. (Pubitemid 36960666)
3. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 2004;25(3):251-255. (Pubitemid 38339632)
4. Rosenthal VD, Maki DG, Salomao R, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006;145(8):582-591. (Pubitemid 46780937)
5. Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006;27(4):349-356.
6. Ramirez Barba EJ, Rosenthal VD, Higuera F, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control 2006;34(4):244-247.
7. Mehta A, Rosenthal VD, Mehta Y, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities: findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007;67(2):168-174.
8. Leblebicioglu H, Rosenthal VD, Arikan OA, et al. Device-associated hospital-acquired infection rates in Turkish intensive care units: findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007;65(3):251-257. (Pubitemid 46268208)
9. Salomao R, Rosenthal VD, Grimberg G, et al. Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008;24(3):195-202.
10. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, et al. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008;24(1):16-24.
11. Rosenthal VD, Maki DG, Mehta A, et al. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008;36(9):627-637.
12. Rosenthal VD. Central line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis 2009;49(12):1899-1907.
13. Madani N, Rosenthal VD, Dendane T, Abidi K, Zeggwagh AA, Abouqal R. Healthcare-associated infections rates, length of stay, and bacterial resistance in an intensive care unit of Morocco: findings of the International Nosocomial Infection Control Consortium (INICC). Int Arch Med 2009;2(1):29.
14. Beyersmann J, Gastmeier P, Grundmann H, et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006;27(5):493-499. (Pubitemid 43835532)
15. Stone PW, Gupta A, Loughrey M, et al. Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24(8):601-606.
16. Graves N, Hakton K, Robertus L. Chapter 17: costs of healthcare associated infection. In: Ferguson J, Cruikshank M, eds. National Surveillance of Health Care Associated Infection in Australia. Canberra: Australian Commission on Safety and Quality in Health Care (ACSQHC), 2008.
17. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated blood-stream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003;31(8):475-480.
18. Higuera F, Rangel-Frausto MS, Rosenthal VD, et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007;28(1):31-35.
19. Basu A, Manning W, Mullahy J. Comparing alternative models: log vs Cox proportional hazard? Health Econ 2004;13:749-765.
20. Schulgen G, Kropec A, Kappstein I, Daschner F, Schumacher M. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000;53:409-417.
21. Graves N, Weinhold D, Birrell F, et al. The effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol 2007;28:280-292.
22. Graves N,Weinhold D, Roberts JAR. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in nonsurgical patients. Health Econ 2005;14(7):755-761.
23. Beyersmann J, Wolkewitz M, Schumacher M. The impact of time-dependent bias in proportional hazards modelling. Stat Med 2008;27(30):6439-6454.
24. Rosenthal V, Graves N, Maki D. An International Nosocomial Infection Control Consortium (INICC) goals and objectives, description of surveillance methods and operational activities. Am J Infect Control 2008;36(9):e1-e12.
25. Edwards JR, Peterson KD, Andrus ML. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control 2007;35:290-301.
26. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007;26(11):2389-2430.
27. Dobson AJ, Barnett AG. An Introduction to Generalized Linear Models. Texts in Statistical Science. 3rd ed. Boca Raton, FL: Chapman & Hall/CRC, 2008.
28. Allignol A. etm: Empirical Transition Matrix. Version 0.4-7. http://cran.r-project.org/web/packages/etm/etm.pdf. Published 2009. Accessed September 14, 2010.
29. Barnett A, Batra R, Graves N, Edgeworth J, Robotham J, Cooper B. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009;170(9):1186-1194.
30. Plummer M. JAGS, version 1.0.3 manual. http://sourceforge.net/projects/ mcmc-jags/files/Manuals/2.0/jags-user-manual.pdf/download. Published September 9, 2008. Accessed September 14, 2010.
31. Plummer M, Best N, Cowles K, Vines K. coda: Output analysis and diagnostics for MCMC. In: 2009:R, version 0.13-4.
32. Beyersmann J, Gastmeier P,Wolkewitz M, Schumacher M. An easymathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008;61:1216-1221.
33. Beyersmann J, Kneib T, Schumacher M, Gastmeier P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009;30:273-276.
34. Kahn JM, Rubenfeld GD, Rohrbach J, Fuchs BD. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. Med Care 2008;46:1226-1233.
35. Roberts RR, Frutos PW, Ciavarella GC, et al. Distribution of fixed vs variable costs of hospital care. JAMA 1999;281(7):644-649.
36. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection - broadening the perspective. Infect Control Hosp Epidemiol 2007;28(2):178-184.
37. Scott RD, Soloman SL, McGowan JE. Applying economic principles to health care. Emerg Infect Dis 2001;7(2):282-285.
38. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an end point. Biometrics 1982;38:163-170.